<DOC>
	<DOCNO>NCT00983645</DOCNO>
	<brief_summary>This study aim compare outcome renal transplant recipient hispanic population base immunosuppressant regimen .</brief_summary>
	<brief_title>A Trial Comparing Prograf Neoral Use Kidney Transplant Recipients Hispanic Ethnicity</brief_title>
	<detailed_description>This study aim include Hispanics undergone renal transplant determine specific outcome renal transplantation , assume ethnic group require different immunosuppressant regimen . Trough level transplant recipient determine dose requirement Tacrolimus Cyclosproine . It recently find , however , test cyclosporine level blood 2 hour take cyclosporine effective dose cyclosprine renal transplant patient trough level . The specific study aim include compare cyclosporine monitoring patient trough C2 level , adjust immunosuppression base C2 level .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Cadaveric Living Donors 18 year old great Primary renal transplant Hispanic ethnicity Prior renal transplant Multiorgan transplant Recipient history Diabetes Mellitus PRA &gt; 20 % Cold Ischemia Time &gt; 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>